Northwest Biotherapeutics, Inc. (NWBO)

Northwest Biotherapeutics Revenue

In the year 2024, Northwest Biotherapeutics had annual revenue of $1.38M, down -28.47%. Northwest Biotherapeutics had revenue of $231.00K in the quarter ending December 31, 2024, a decrease of -48.09%.

• Revenue: 1.38M
• Revenue Growth: -28.47%
• P/S Ratio: 281.85
• Revenue / Employee: 55.28K
• Employees: 25
• Market Cap: 389.52M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.38M	-550.00K	-28.47%
Dec 31, 2023	1.93M	249.00K	14.80%
Dec 31, 2022	1.68M	678.00K	67.46%
Dec 31, 2021	1.01M	-286.00K	-22.15%
Dec 31, 2020	1.29M	-1.12M	-46.43%